GenapSys, Inc. is committed to a new era of applied genomic testing and a new paradigm for medical sequencing. We are developing a cost-disruptive, easy-to-use genomic diagnostic system based on our simple label-free proprietary GENIUS™ technology which delivers 100x improvement in cost and speed. These innovations will enable a new era of medicine through the widespread acquisition of genomic data for research and testing of genetic disease, cancer, and microbes.

Research Grants 11 show all






Patents 128show all

  • 60
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 40
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 31
    B01L - Chemical or physical laboratory apparatus for general use
  • 27
    B03C - Magnetic or electrostatic separation of solid materials from solid materials or fluids
  • 23
    C40B - Combinatorial chemistry
  • 19
    H01L - Semiconductor devices
  • 16
    B01D - Separation
  • 15
    C12N - Microorganisms or enzymes
  • 11
    A61K - Preparations for medical, dental, or toilet purposes
  • 9
    B01J - Chemical or physical processes, e.g. catalysis or colloid chemistry

Contact Information

200 Cardinal Way Third Floor
Redwood City, CA 94063
United States


Total FundingEmployeesLast Funding DateStatus

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2020-02-06$75,000,000Series UnknownOxford Finance LLC
2019-11-21$90,000,000Series CForesite Capital
2018-01-15$32,500,000Series C
2017-03-30Convertible Note
2013-03-22$8,500,000Series ADecheng Capital
2013-11-14$37,500,000Series BIPV CapitalDecheng Capital
2012-05-18Convertible NotePlug and Play